Organization
UCB Pharma, Raleigh, United States of America
1 abstract
Abstract
ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITISOrg: Sorbonne Université and Pitié Salpétriere Hospital, Paris, France, Swedish Medical Center and University of Washington, Seattle, United States of America, Icahn School of Medicine at Mount Sinai, New York, United States of America, Hospital of the University of Pennsylvania, Philadelphia, United States of America, UCB Pharma, Slough, United Kingdom,